Scarpignato, Carmelo http://orcid.org/0000-0001-5645-857X
Hunt, Richard H.
Article History
Accepted: 17 December 2020
First Online: 25 January 2021
Change Date: 11 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11938-021-00343-0
Compliance with Ethical Standards
:
: Carmelo Scarpignato has served as a speaker, consultant, and/or advisory board member for Alfasigma, Pfizer, Takeda, Reckitt-Benkiser, and Shionogi, and has in the past received funding from Giuliani Pharmaceuticals and Pfizer.Richard Hunt has been a Consultant or Speaker for Biocodex, Cinclus, Daewoong, Danone, Dr. Reddy, Insys, and Takeda.
: This article does not contain any studies with human or animal subjects performed by any of the authors.